IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
MDS/AML
University Hospital Tuebingenmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the MDS/AML cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Thiotepa University Hospital Tuebingen | Phase 2 | CCC |
Fludarabine University Hospital Tuebingen | Phase 2 | CCC |
Evomela University Hospital Tuebingen | Phase 2 | CCC |
Hydroxyurea University Hospital Tuebingen | Phase 2 | CCC |
ROPEGINTERFERON ALFA-2B M.D. Anderson Cancer Center | Phase 1/2 | CC |
Azacitidine M.D. Anderson Cancer Center | Phase 1/2 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →